The company has concluded our acquisition of Richcore Lifesciences on 20th Jan 2021.
Novartis India posts Q2 FY26 PAT at Rs. 24.22 Cr
Granules India’s facility secures FDA EIR with 'VAI’
Lilly to invest $1.2 billion+ to boost oral medicine manufacturing capacity in US
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
